Back | Next |
home / stock / mrna / mrna message board
Subject | By | Source | When |
---|---|---|---|
They just wanted to drop the price so | Civil War General | investorshub | 04/18/2023 11:08:13 AM |
The profound observed reduction in the risk of | axelvento | investorshub | 04/18/2023 4:12:01 AM |
the results of the trial- which shows reduced | axelvento | investorshub | 04/18/2023 3:26:52 AM |
Yes as always! | axelvento | investorshub | 04/18/2023 2:56:52 AM |
Thats nonsense | Civil War General | investorshub | 04/17/2023 9:21:03 PM |
The news on the cancer vaccine was fine, | DewDiligence | investorshub | 04/17/2023 8:11:59 PM |
And on Monday with this excellent news the | Civil War General | investorshub | 04/17/2023 7:36:46 PM |
That is old fried rice from Catherine Wu | NY1972 | investorshub | 04/17/2023 11:57:04 AM |
the story continues-with phase 3 launch before year-end! | axelvento | investorshub | 04/17/2023 3:26:08 AM |
additional subgroup analysis data will be presented during | axelvento | investorshub | 04/17/2023 3:20:35 AM |
More on mRNA-1427 from Evaluate Vantage: | DewDiligence | investorshub | 04/16/2023 10:29:14 PM |
Thanks. Your previous two posts had the information | DewDiligence | investorshub | 04/16/2023 9:47:23 PM |
Slides https://s29.q4cdn.com/435878511/files/doc presentations/2023/Apr/16/MMA-7 | jondoeuk | investorshub | 04/16/2023 9:27:30 PM |
https://finance.yahoo.com/news/moderna-merck-announce-mrna-4157-150000175.html | jondoeuk | investorshub | 04/16/2023 3:22:25 PM |
Dr. Weber will give an oral presentation today https://www.abstractsonline.com/pp8/#!/10828/presenta | jondoeuk | investorshub | 04/16/2023 2:03:38 AM |
imo...$MRNA is a POS trainwreck~ | IHuser | investorshub | 04/15/2023 11:10:13 PM |
When will the full dataset be presented? | DewDiligence | investorshub | 04/15/2023 5:57:47 PM |
https://twitter.com/TedAshburn/status/1646649256206299136 | jondoeuk | investorshub | 04/13/2023 11:04:30 PM |
US Court Favors Moderna In COVID-19 Vaccine Patent | axelvento | investorshub | 04/13/2023 1:22:10 PM |
Moderna said it expects to see between $8 | axelvento | investorshub | 04/12/2023 11:13:32 AM |
News, Short Squeeze, Breakout and More Instantly...
2024-05-02 18:36:00 ET Moderna (NASDAQ: MRNA) was a fine stock to heal an ailing portfolio on the second-to-last trading day of the week. The company, which developed and sells the Spikevax COVID-19 vaccine, saw its share price balloon by almost 13% thanks to an encouraging set of q...
Thursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an income of $(0.19), smaller than the c...
After topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co Inc (NYSE: MRK) just reported encouragin...